WednesdayOct 19, 2022 12:15 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Receives Approval to Move Forward with ELSM Acquisition

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received approval from the U.S. Bankruptcy Court to move forward on its acquisition of Electric Last Mile Solutions (“ELMS”) assets; ELSM is an electric vehicle company. According to the announcement, the Chapter 7-approved transaction paves the way for Mullen to acquire ELMS’s manufacturing plant along with all inventory and intellectual property. The acquisition will be an all-cash purchase; the company’s cash on hand and a funding commitment of up to $240 million provides the funds to finalize the acquisition and move forward with vehicle launches. The company noted that…

Continue Reading

WednesdayOct 19, 2022 10:50 am

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Breaks Ground at Core RNG Expansion Project, Provides Construction Update

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) today announced that construction has commenced at the company’s Core RNG Expansion Project at Fraser Valley Biogas. Located in Abbotsford, British Columbia, Fraser Valley Biogas (“FVB”) has been in operation since 2011 and is the original producing renewable natural gas (“RNG”) project in Western Canada to supply FortisBC’s network. The facility produces RNG by combining anaerobic digestion and biogas upgrading, primarily by converting agricultural waste from local dairy farms. Once complete, RNG production volumes at the FVB Core RNG expansion project are expected to double the capacity of the facility to produce ~160,000 GJ of…

Continue Reading

WednesdayOct 19, 2022 9:30 am

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Featured on Stock Day Podcast

MetAlert (OTC: MLRT), a pioneer in smart, mobile and wearable tracking and recovery location-based solutions, was featured on a recent episode of the Stock Day Podcast. MetAlert’s CEO Patrick Bertagna joined Stock Day host Everett Jolly to discuss the company’s background, current projects and focus. “We have expanded the capabilities of our SmartSole(R) platform. We have added Bluetooth, WI-FI and sensors inside of the hardware platform, which will allow us to monitor not just where someone is but also how they are doing... We are also going to be adding products that monitor how people are doing at home... On…

Continue Reading

TuesdayOct 18, 2022 2:08 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Innovative Robot Roadshow Makes Stop in Dallas

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), and its Robot Roadshow are spending the day in Dallas. The roadshow is a free, engaging experiential event that is designed to provide potential clients, media and investors with an opportunity to see Knightscope’s game-changing security robots up close and personal. The stop in Dallas is at the Commemorative Air Force location from 10 a.m. to 3 p.m. CT. Knightscope is committed to share its offerings through creative marketing events, and the roadshow is an ideal example of this. So far, the event has landed in 64 different locations…

Continue Reading

TuesdayOct 18, 2022 1:30 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Release of Q3 2022 Results, Conference Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has announced that it will provide a business update and release its financial results for the third quarter of 2022 following the close of the market on Tuesday, Nov. 8, 2022. In addition, Cepton will hold a conference call and webcast at 2:30 p.m. PT (5:30 p.m. ET) that same day. Interested parties may join the call by dialing 888-999-6281 and visiting https://ibn.fm/01a5B for the live webcast. A replay will be available approximately two hours after the live call and until Nov. 22, 2022, and can be…

Continue Reading

TuesdayOct 18, 2022 12:59 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Agreement with Columbia University to Extend Research Pact

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has entered into an agreement with Columbia University to extend its current research partnership efforts. The agreement outlines certain assets that are currently under development regarding the work of associate professor of clinical Neurobiology Dr. Christine Ann Denny at Columbia University Irving Medical Center. Denny and her team are studying the molecular mechanisms underlying learning and memory, including diseases such as Alzheimer’s disease. According to the announcement, Denny’s pioneering research is evaluating whether ketamine and novel inventions associated with the substance have potential…

Continue Reading

TuesdayOct 18, 2022 12:40 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Reports Assay Results from Iska Iska Drills

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, has been conducting an ongoing drilling program at its Iska Iska silver-tin polymetallic project and is reporting on two diamond drill holes. According to the announcement, drill hole DSB-36 collared 400m southeast of the Santa Barbara adit, tested the extension of the core of the high-grade feeder zone at Santa Barbara while hole DSB-34 tested the potential southwest limits of the high-grade feeder zone. Eloro noted that so far 118 drill holes have…

Continue Reading

TuesdayOct 18, 2022 12:32 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) CEO Joins Hercules Electric Mobility CEO to Discuss New Deal

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF), a clean-technology company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, has signed an agreement with Hercules Electric Mobility to bring customizable electric mobility products to market. Leaders from the two companies — HLRTF CEO Don Currie and Hercules Electric Mobility CEO James Breyer — discussed the partnership on a recent Proactive interview with host Steve Darling, noting that the partnership is aimed at integrating the latest technologies into new, innovative products and accelerating the path to market. To view the full interview, visit https://ibn.fm/BzwI1 To view…

Continue Reading

MondayOct 17, 2022 2:34 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Featured in BioWorld(TM) MedTech Article

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed an innovative platform for heart attack detection anytime, anywhere, was featured in a recent BioWorld(TM) MedTech article. “HeartBeam Inc. has been awarded a patent for what it called ‘the first and only’ 3D-vector, 12-lead ECG platform for heart attack detection, this in conjunction with a credit card-sized device inside a consumer’s wallet for personal monitoring,” the piece reads. “The company said it can record and remotely transmit a set of cardiac signals to a physician for review so that patients at high risk of cardiac arrest are not left alone…

Continue Reading

MondayOct 17, 2022 1:35 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Continues Focus to Create the Best Psychedelic Therapies for Patients

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is conducting a phase 1/2a trial evaluating CYB003, its lead investigational molecule and the first-ever novel psilocybin analog to enter clinical development. “The in-human trial is critical to the company’s continued development of CYB003, a deuterated psilocybin analog that Cybin believes has potential to successfully address the challenges and limitations of oral psilocybin. According to the company’s preclinical research, CYB003 achieved less variability in plasma levels, along with faster onset of action, improved brain penetration, and shorter duration…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered